Stocks › CGON
CG Oncology CGON
US equityMarket cap rank #1717
$79.47 −$2.43 (-2.97%)
Market closed · Nov 22, 5:50 am ET · Last extended-hours $79.50 +0.04%
Open$80.32
Prev close$81.90
Day range$79.21 – $83.16
Volume1.67M
Market cap$7.10B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts8
Average target$90.00+13.3% vs. price
- Buy 100%
Low $80.00Now $79.47Avg $90.00High $102.00
Recent rating changes
The last 20 actions on file set price targets from $79.00 to $108.00, averaging $91.21.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 13 Nov 2026 | Morgan Stanley | BUY | $102.00 |
| 9 Nov 2026 | Wedbush | BUY | $84.00 |
| 9 Nov 2026 | Guggenheim | BUY | $89.00 |
| 6 Nov 2026 | JonesTrading | BUY | $85.00 |
| 6 Nov 2026 | H.C. Wainwright | BUY | $100.00 |
| 6 Nov 2026 | RBC Capital | BUY | $80.00 |
| 10 Sep 2026 | Truist Financial | BUY | – |
| 21 Aug 2026 | UBS | BUY | $90.00 |
| 20 Aug 2026 | UBS | BUY | $90.00 |
| 17 Aug 2026 | Morgan Stanley | BUY | $93.00 |
| 11 Aug 2026 | Truist Financial | BUY | $85.00 |
| 7 Aug 2026 | LifeSci Capital | BUY | $108.00 |
| 7 Aug 2026 | Piper Sandler | BUY | $85.00 |
| 7 Aug 2026 | BofA Securities | BUY | $88.00 |
| 7 Aug 2026 | Truist Financial | BUY | $85.00 |
| 7 Aug 2026 | H.C. Wainwright | BUY | $100.00 |
| 6 Aug 2026 | Cantor Fitzgerald | BUY | $105.00 |
| 6 Aug 2026 | JonesTrading | BUY | $85.00 |
| 6 Aug 2026 | H.C. Wainwright | BUY | $100.00 |
| 6 Aug 2026 | RBC Capital | BUY | $79.00 |
No comments yet — be the first to weigh in on CGON.
Sign in to join the discussion.